1-6 of 6
Jamshid Sorouri Khorashad
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NF-κB-Dependent Activation of the Proteasome Components, PSMD1 and PSMD3, As a Mechanism of Resistance to Imatinib

Idaly Maria Olivas, BS, Joshua Lara, BS, Rebecca Ellwood, MS, Carme Ripoll Fiol, MS, Andres J Rubio, MS, Alfonso Enrique Bencomo, PhD, Mayra Alejandra Gonzalez, BS, Georgios Nteliopoulos, PhD, Alistair Reid, BSc, PhD, Dragana Milojkovic, MBBS, MD, Jane Apperley, MB, ChB, MD, Jamshid Sorouri Khorashad, MD PhD FRCPath, Anna M. Eiring, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2923.
https://doi.org/10.1182/blood-2019-126963
Published: 2019
Journal Articles

Selective Inhibition of Nucleocytoplasmic Transport Overcomes Ruxolitinib Resistance in Myelofibrosis

Dongqing Yan, Srinivas K. Tantravahi, MBBS, Anthony D. Pomicter, MS, Clinton C. Mason, PhD, Anna Senina, MS, Qiang Wang, PhD, Jamshid Sorouri Khorashad, MD PhD FRCPath, Hein Than, MD FRCPath, MRCP, Phillip M. Clair, MS, William L. Heaton, MS, Anna M. Eiring, PhD, Josef T. Prchal, MD, Sabina I. Swierczek, PhD, Erkan Baloglu, Sharon Shacham, PhD MBA, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1660.
https://doi.org/10.1182/blood.V130.Suppl_1.1660.1660
Published: 2017
Journal Articles

Persistence of Somatic Mutation Spectrum and Clonal Architecture in Chronic Myelomonocytic Leukemia Treated with Hypomethylating Agents

Hein Than, MD FRCPath, MRCP, Yi Qiao, PhD, Xiaomeng Huang, PhD, Dongqing Yan, Jamshid Sorouri Khorashad, MD PhD FRCPath, Anthony D. Pomicter, MS, Anca Franzini, PhD, Tibor Kovacsovics, Thomas O'Hare, PhD, Gabor T. Marth, DSc, Michael W. Deininger, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2527.
https://doi.org/10.1182/blood.V130.Suppl_1.2527.2527
Published: 2017
Journal Articles

An Unbiased shRNA Library Screen Identifies Nucleocytoplasmic Transport As a Potential Target For Treatment Of Chronic Myeloid Leukemia

Jamshid Sorouri Khorashad, MD, PhD, FRCPath, Clinton C. Mason, PhD, Ira L. Kraft, BS, Kimberly R. Reynolds, MS, Anthony D. Pomicter, MS, Anna M. Eiring, PhD, Matthew S. Zabriskie, Anthony J Iovino, William Heaton, Srinivas K. Tantravahi, MBBS, MRCP, Michael Kauffman, MD, PhD, Sharon Schacham, PhD, MBA, Alex Chenchik, PhD, Kyle Bonneau, PhD, Thomas O'Hare, Michael W. Deininger, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2707.
https://doi.org/10.1182/blood.V122.21.2707.2707
Published: 2013
Journal Articles

EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors

Brief Report
Mustafa Daghistani, David Marin, Jamshid Sorouri Khorashad, Lihui Wang, Philippa C. May, Christos Paliompeis, Dragana Milojkovic, Valeria A. De Melo, Gareth Gerrard, John M. Goldman, Jane F. Apperley, Richard E. Clark, Letizia Foroni, Alistair G. Reid
Journal: Blood
Blood (2010) 116 (26): 6014–6017.
https://doi.org/10.1182/blood-2010-01-264234
Published: 2010
Includes: Supplemental data
Journal Articles

BCR-ABL1 Oncogene Down-regulates the Expression of OCT1 in CML.

Alexandra Bazeos, David Marin, Gareth Gerrard, PhD, Richard Szydlo, Dragana Milojkovic, MD, Alistair Reid, Hugues de Lavallade, Jane F. Apperley, MBChB, FRCP, FRCPath, John M Goldman, DM, FCRP, FRCPath, Letizia Foroni, Jamshid Sorouri Khorashad, MD
Journal: Blood
Blood (2009) 114 (22): 3248.
https://doi.org/10.1182/blood.V114.22.3248.3248
Published: 2009